Inventor · disambiguated record
Andrew Luster
Also filed as: LUSTER ANDREW · LUSTER ANDREW D · LUSTER ANDREW DAVID
12 granted patents·4 pending applications·438 citations·filing 1994–2024
93Inventor score
Files withHARVARD COLLEGE6GEN HOSPITAL CORP4VOLUTION IMMUNO PHARMACEUTICALS SA2BRIGHAM & WOMENS HOSPITAL1MASSACHUSETTS INST TECHNOLOGY1
Top patents by PatentIndex Score
16 records- 0197US5474981AUse of the cytokine IP-10 as an anti-tumor agentHARVARD COLLEGE·Filed 1994·Granted Dec 12, 1995·240 cites·5 claims
- 0288US7775469B2Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2006·Granted Aug 17, 2010·9 cites·17 claims
- 0388US6780973B1Eotaxin: an eosinophil chemoattractantHARVARD COLLEGE·Filed 2000·Granted Aug 24, 2004·27 cites·9 claims
- 0486US7141363B2Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2002·Granted Nov 28, 2006·20 cites·13 claims
- 0586US6403782B1Nucleic acid encoding eotaxinHARVARD COLLEGE·Filed 1999·Granted Jun 11, 2002·54 cites·11 claims
- 0677US5824299AModulation of endothelial cell proliferation with IP-10HARVARD COLLEGE·Filed 1995·Granted Oct 20, 1998·41 cites·13 claims
- 0774US6673915B1Nucleic acid encoding monocyte chemotactic protein 4GEN HOSPITAL CORP·Filed 2000·Granted Jan 6, 2004·9 cites·4 claims
- 0874US2025195612A1Coversin for use in the treatment of rheumatic diseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2024·Application pending·0 cites
- 0969US6949637B2Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphismGEN HOSPITAL CORP·Filed 2003·Granted Sep 27, 2005·1 cites·2 claims
- 1064US6548245B1Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphismBRIGHAM & WOMENS HOSPITAL·Filed 1998·Granted Apr 15, 2003·25 cites·30 claims
- 1162US2022047673A1Coversin for Use in the Treatment of Rheumatic DiseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1253US6153600AUse of the cytokine IP-10 as an anti-tumor agentHARVARD COLLEGE·Filed 1999·Granted Nov 28, 2000·7 cites·4 claims
- 1350US11485781B2Multiple specificity binders of CXC chemokinesMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Nov 1, 2022·0 cites·15 claims
- 1448US5935567ACytokine IP-10 as an anti-tumor agentHARVARD COLLEGE·Filed 1995·Granted Aug 10, 1999·5 cites·6 claims
- 1548US2010143381A1Lysophosphatidic acid receptor targeting for lung diseaseTAGER ANDREW·Filed 2008·Application pending·0 cites
- 1646US2001033841A1Modulating platelet functionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Luster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →